Last updated on February 2019

Study to Investigate the Efficacy and Safety of Dupilumab Administered With Topical Corticosteroids (TCS) in Participants 6 to <12 Years With Severe Atopic Dermatitis (AD)


Brief description of study

The main objective of the trial is to demonstrate the efficacy of dupilumab administered concomitantly with topical corticosteroids (TCS) in participants 6 years to <12 years of age with severe atopic dermatitis (AD).

The secondary objective is to assess the safety of dupilumab administered concomitantly with TCS in patients 6 years to <12 years of age with severe AD.

Clinical Study Identifier: NCT03345914

Contact Investigators or Research Sites near you

Start Over

Clinical Trials Administrator

Regeneron Investigational Site
Birmingham, AL United States
  Connect »

Clinical Trials Administrator

Regneron Investigational Site
Bakersfield, CA United States
  Connect »

Clinical Trials Administrator

Regeneron Investigational Site
Mission Viejo, CA United States
  Connect »

Clinical Trials Administrator

Regeneron Investigational Site
Macon, GA United States
  Connect »

Clinical Trials Administrator

Regeneron Investigational Site
Rockville, MD United States
  Connect »

Clinical Trials Administrator

Regeneron Investigational Site
San Antonio, TX United States
  Connect »

Clinical Trials Administrator

Regeneron Investigational Site
Norfolk, VA United States
  Connect »

Clinical Trials Administrator

Regeneron Investigational Site
Long Beach, CA United States
  Connect »

Clinical Trials Administrator

Regeneron Investigational Site
Coral Gables, FL United States
  Connect »

Clinical Trials Administrator

Regeneron Investigational Site
Sandy Springs, GA United States
  Connect »

Clinical Trials Administrator

Regeneron Investigational Site
Forest Hills, NY United States
  Connect »

Clinical Trials Administrator

Regeneron Investigational Site
New York, NY United States
  Connect »

Clinical Trials Administrator

Regeneron Investigational Site
Bellaire, TX United States
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.